Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
0.00%
)
US TECH 100
25,946.80
(
0.29%
)
Dow Jones
49,447.43
(
0.00%
)
Brent Oil
91.74
(
1.17%
)
Bitcoin
76,032.00
(
0.18%
)
News Focus
News Focus
Post# of 822168
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

hope4patients

Send PM Follow Ignore
Followers 46
Posts 2717
Boards Moderated 0
Alias Born 12/19/2015

hope4patients

Re: exwannabe post# 374146

Monday, 05/03/2021 2:03:40 PM

Monday, May 03, 2021 2:03:40 PM

Post# of 822168
This post is absolutely false. Over 300 of the screened patients did NOT even have GBM! See slides 11 & 16
https://nwbio.com/wp-content/uploads/Boston-Presentation-v0.2.pdf

Also the patient demographics are comparable to other GBM trials, especially w/ respect to known prognostic factors. 75% of the patients are over 50 and more of the patients are unmethylated.

The trial excluded early progressives and pseudoprogressors JUST LIKE the following recent trials:
Stupp et al. 2015, 2017
Weller et al. 2017
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News